tirzepatide and b12 compound Compounded for Women Compounded Tirzepatide Injections $100 |

Clinical trials show average weight loss of 15% to 20% of body weight with tirzepatide treatment

The risk-benefit math does not support that

Williams, R.T., et al

FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), exenatide (Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist

In cases where L-carnitine supplementation proves ineffective or contraindicated, exploring alternative interventions such as dietary modifications, lifestyle changes, or pharmacological agents targeting related pathways may be necessary to address metabolic stress and improve oocyte quality